Cromos™ Pharma is a premier regional CRO with operations in Central and Eastern Europe, former Soviet republics and Israel
Cromos Pharma is a regional contract research organization (CRO) that specializes in biopharmaceutical clinical outsourcing to Georgia, Belarus, Russia, Ukraine, countries of Eastern Europe, Israel and Baltic states – areas with very compelling environment for biopharmaceutical research. The company manages Phase I-IV clinical trials, bioequivalence and observational studies and has been successfully operating since 2004.
Our business model is a product of the most validated Western solutions which are carefully tailored to local environments. Estonia
Full compliance with ICH GCP regulations, motivated and experienced investigators with impeccable reputations, large patient population is the integral to our ability to provide high quality and affordable services.
As project managers, our "summa cum laude" MDs and PhDs don't just flawlessly adhere to a study protocol, they appreciate the science behind it. By choosing Cromos Pharma you get an invariable guarantee that your project will be handled by the "A-team".
In 2012 Cromos Pharma has adopted a fully integrated, cloud-based, virtual workplace model. This has allowed for seamless integration of all offices and employees, significantly increased the company's productivity and reduced its overhead.
Another differentiator that stands us apart from the competition is Cromos Pharma's unique risk-sharing model in transactions with biotech, pharma and device companies who it considers to have promising drug candidates and medical technologies.Estonia & Lithuania The company offers several business partnership algorithms, including clinical research and trial conduct at a substantially reduced cost or in exchange for equity and licensing deals.
Please, contact us to learn more about Cromos Pharma clinical trial services.
clinical trials in Baltic states
Clinical monitoring in Eastern Europe & Estonia
Cromos™ Pharma launches Corium Research, a premier dermatology site research organization / 18.11.2014
Cromos™ Pharma at New York CEO Conference / 07.10.2014
Cromos™ Pharma CEO, Dr. Bogin, will be presenting at MAGI Clinicаl Research Conference that takes place in San Francisco on November 9-12, 2014 / 07.10.2014
Cromos Pharma conducted the webinar “SWOT analysis of сlinical triаls in post-Soviet countries” / 31.07.2014